课题基金 / 基金详情

INTERLEUKIN 12 FUNCTION DURING MURINE LEISHMANIASIS

INTERLEUKIN 12 FUNCTION DURING MURINE LEISHMANIASIS
鼠利什曼病期间白细胞介素 12 的功能
批准号:
2671352
负责人:
FREDERICK P. HEINZEL
金额:
$6.93万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-01 至 1999-08-31

项目摘要

项目成果

FREDERICK P. HEINZEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cure and progression of murine leishmaniasis are mediated by reciprocal expansions of functionally distinct Th1 and Th2 CD4+ lymphocyte subsets. The long term goal of these studies is to understand cytokine-based mechanisms responsible for biased CD4+ subset responses. The immediate goals are to characterize the function and regulation of IL-12 during leishmaniasis. The requested salary support will provide protected research time necessary to perform the studies described, to develop an independent career and to strengthen collaborations within the applicant institution that will enhance both personal and institutional goals. CWRU School of Medicine is committed to immunoparasitologic research and provides a productive supportive environment for career development in this field, as indicated by the existence of a free -standing Division of Geographic Medicine and by the assignment of the P.I. to a tenure track position. We propose that IL-12 produced in response to infection critically regulates CD4+ lymphocyte responses in vivo. IL-12 is a heterodimeric T-cell growth and IFN-gamma stimulatory cytokine that is produced by B- cells and macrophages. Preliminary studies show that treatment of susceptible BALB/c mice with recombinant IL-12 restores fully curative Th1 immunity during infection with L. major. Moreover, the production of IL-12 is increased significantly in healing C57BL/6 mice compared to nonhealing BALB/c mice. We hypothesize that IL-12 produced during infection promotes curative CD4+ Th1 responses and that differences in the production of IL-12 by infected BALB/c and C57BL/6 mice account for their disparate responses to leishmaniasis. The proposed studies of IL- 12 production and function in BALB/c and C57BL/6 mice during leishmaniasis may provide unique mechanistic insights into how parasitic infection effects Th1 and Th2 responses that determine the course of disease. Specific aims are to: 1) Examine the role of IL-12 in promoting Th1 CD4+ subset selection and curative immunity in BALB/c and C57BL/6 mice infected with Leishmania major. 2) Identify differences in the production of IL-12 by BALB/c and C57BL/6 mice during leishmaniasis. 3) Analyze the role of IL-12 in the in vitro differentiation of L major - specific CD4+ T cell subsets. 4) Identify stimuli that result in IL-12 release by B-lymphocytes and macrophages during murine leishmaniasis.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Immunoregulation of murine leishmaniasis by interleukin-12.
IL-12 对小鼠利什曼病的免疫调节。
DOI: 10.1016/0923-2494(96)83034-3
发表时间: 1995
期刊: Research in immunology
影响因子: --
作者: [Heinzel,FP, Ahmed,F, Hujer,AM, Rerko,RM]
通讯作者: Rerko,RM
Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice.
内源性 IL-12 是控制 Th2 细胞因子反应所必需的,该反应能够加剧正常耐药小鼠的利什曼病。
DOI: --
发表时间: 1995
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Heinzel,FP, Rerko,RM, Ahmed,F, Pearlman,E]
通讯作者: Pearlman,E
Endotoxin fails to induce IFN-gamma in endotoxin-tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness.
内毒素不能在内毒素耐受小鼠中诱导 IFN-γ:IL-12 异二聚体产生和 IL-12 反应性均存在缺陷。
DOI: --
发表时间: 1999
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Balkhy,HH, Heinzel,FP]
通讯作者: Heinzel,FP
Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
使用抗 CTLA4 抗体治疗后,易感 BALB/c 小鼠皮肤利什曼病的加速不依赖于白细胞介素 4。
DOI: 10.1128/iai.67.12.6454-6460.1999
发表时间: 1999
期刊: Infection and immunity
影响因子: 3.1
作者: [Heinzel,FP, MaierJr,RA]
通讯作者: MaierJr,RA
10
    ENDOTOXIN TOLERANCE AS A MODEL FOR IMMUNE PARALYSIS
    • 批准号:
      6127300
    • 项目类别:
    • 资助金额:
      $25.41万
    • 财政年份:
      2000
    • 负责人:
      FREDERICK P. HEINZEL
    • 依托单位:
    ENDOTOXIN TOLERANCE AS A MODEL FOR IMMUNE PARALYSIS
    • 批准号:
      6632103
    • 项目类别:
    • 资助金额:
      $25.8万
    • 财政年份:
      2000
    • 负责人:
      FREDERICK P. HEINZEL
    • 依托单位:
    ENDOTOXIN TOLERANCE AS A MODEL FOR IMMUNE PARALYSIS
    • 批准号:
      6511013
    • 项目类别:
    • 资助金额:
      $25.8万
    • 财政年份:
      2000
    • 负责人:
      FREDERICK P. HEINZEL
    • 依托单位:
    ENDOTOXIN TOLERANCE AS A MODEL FOR IMMUNE PARALYSIS
    • 批准号:
      6362421
    • 项目类别:
    • 资助金额:
      $25.8万
    • 财政年份:
      2000
    • 负责人:
      FREDERICK P. HEINZEL
    • 依托单位:
    海外基金